Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ilse A. Moreno-Arquieta"'
Autor:
Gisela Garcia-Arellano, Adrian Camacho-Ortiz, Ilse Andrea Moreno-Arquieta, Jesus Alberto Cardenas-de la Garza, Diana Carolina Rubio-Torres, Elvira Garza-Gonzalez, Paola Bocanegra-Ibarias, Dionicio Angel Galarza-Delgado
Publikováno v:
The American Journal of the Medical Sciences. 365:215-217
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7e9cd8952e8ef6ee4f2b039c824d71f
https://doi.org/10.1016/j.amjms.2022.10.012
https://doi.org/10.1016/j.amjms.2022.10.012
Autor:
Luis R. García-Chairez, Fred A. Montelongo-Rodríguez, Ilse A. Moreno-Arquieta, Max Molina Ayala, Adrián Gutierrez-González
Publikováno v:
Ochsner Journal. 22:273-276
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6a233ac931e1ecfbd8c0d777a80fff3
https://doi.org/10.31486/toj.21.0120
https://doi.org/10.31486/toj.21.0120
Autor:
Adrian Cuellar-Barboza, Janett Riega-Torres, Jorge A. Esquivel-Valerio, Ilse Andrea Moreno-Arquieta, Jorge Ocampo-Candiani, Jesus Alberto Cardenas-de la Garza, Maira Elizabeth Herz-Ruelas, Dionicio Ángel Galarza-Delgado
Publikováno v:
Journal of Dermatological Treatment. 33:1765-1768
Eosinophilic fasciitis (EF) is an uncommon autoimmune connective tissue disorder characterized by edema, erythema, and subsequent induration of the extremities. It is commonly treated with corticosteroids but there is no treatment ladder for immunosu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a4f10f45cb1ac3cad119e07a5e15991
https://doi.org/10.1080/09546634.2021.1890682
https://doi.org/10.1080/09546634.2021.1890682
Autor:
Ilse Andrea Moreno-Arquieta, Cassandra Michele Skinner-Taylor, Jorge A. Esquivel-Valerio, Patricia Ludivina Gonzalez-Garcia, Fatima Del Rocio Almaraz-Juarez, Gisela García-Arellano, Dioncio Angel Galarza-Delgado, Jesus Alberto Cardenas-de la Garza
Publikováno v:
Rheumatology International
Data regarding COVID-19 vaccine efficacy and adverse events (AE) in patients with autoimmune and inflammatory rheumatic diseases (AIIRD) have been published recently although these mostly include the mRNA vaccines (Pfizer-BioNTech and Moderna) and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58bbc8d4751daf4857b9008d6ce5a2e4
https://pubmed.ncbi.nlm.nih.gov/34622311
https://pubmed.ncbi.nlm.nih.gov/34622311